Ahead of the Bell: Alkermes upgraded on 3Q results (INO News)

More info…
(AP:NEW YORK) Strong sales of a schizophrenia drug during the third quarter prompted an analysts to upgrade shares of Alkermes Inc. on Friday. Shares jumped 10 percent, or $1.10, to $11.62 in premarket trading.

official drug abuse hotline